source
- STAT+: Spring forward forever? Another daylight saving debate arrives in CongressTrump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning RoundsSTAT · 14d ago↗ source
- STAT+: Amylyx nears pivotal endocrine drug study readoutAmylyx Pharmaceuticals will soon read out results from a study evaluating a new treatment for a rare endocrine disorder, a pivotal moment for patients and the company.STAT · 14d ago↗ source
- Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 updateTakeda has unveiled more data from its phase 3 trials of zasocitinib, demonstrating that the once-daily pill was able to clear or almost clear scalp psoriasis in 75% of patients.Fierce Biotech